Hypera SA Financials
| HYPE3 Stock | BRL 20.27 0.09 0.45% |
Hypera |
Understanding current and past Hypera SA Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Hypera SA's financial statements are interrelated, with each one affecting the others. For example, an increase in Hypera SA's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Hypera SA's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Hypera SA. Check Hypera SA's Beneish M Score to see the likelihood of Hypera SA's management manipulating its earnings.
Hypera SA Stock Summary
Hypera SA competes with Engie Brasil, WEG SA, Ambev SA, and M Dias. It offers branded prescription products under the Mantecorp Farmasa, Episol, Predsim, Alivium, Lisador, Rinosoro, Celestamine, Maxsulid, Diprospan, Mioflex-A, and Addera D3 brands dermo-cosmetics products under the Mantecorp Skincare brands and consumer health products under the Apracur, Benegrip, Coristina d, Engov, Epocler, Estomazil, and other brands. Hypera S.A. was founded in 2001 and is headquartered in So Paulo, Brazil. HYPERA ON operates under Drug ManufacturersSpecialty Generic classification in Brazil and is traded on Sao Paolo Stock Exchange. It employs 8918 people.| Instrument | Brazil Stock View All |
| Exchange | Sao Paulo Exchange |
| ISIN | BRHYPEACNOR0 |
| Business Address | Av Magalhes de |
| Sector | Pharmaceuticals |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.hyperapharma.com.br |
| Phone | 55 11 3627 4206 |
| Currency | BRL - Brazilian Real |
You should never invest in Hypera SA without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Hypera Stock, because this is throwing your money away. Analyzing the key information contained in Hypera SA's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Hypera SA Key Financial Ratios
There are many critical financial ratios that Hypera SA's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Hypera SA reports annually and quarterly.| Return On Equity | 0.16 | |||
| Return On Asset | 0.0686 | |||
| Target Price | 53.34 | |||
| Beta | 0.24 | |||
| Z Score | 2.4 |
Hypera Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Hypera SA's current stock value. Our valuation model uses many indicators to compare Hypera SA value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Hypera SA competition to find correlations between indicators driving Hypera SA's intrinsic value. More Info.Hypera SA is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers reporting about 0.42 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Hypera SA is roughly 2.37 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Hypera SA's earnings, one of the primary drivers of an investment's value.Hypera SA Systematic Risk
Hypera SA's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Hypera SA volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twelve with a total number of output elements of fourty-nine. The Beta measures systematic risk based on how returns on Hypera SA correlated with the market. If Beta is less than 0 Hypera SA generally moves in the opposite direction as compared to the market. If Hypera SA Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Hypera SA is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Hypera SA is generally in the same direction as the market. If Beta > 1 Hypera SA moves generally in the same direction as, but more than the movement of the benchmark.
Hypera SA November 25, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Hypera SA help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Hypera SA. We use our internally-developed statistical techniques to arrive at the intrinsic value of Hypera SA based on widely used predictive technical indicators. In general, we focus on analyzing Hypera Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Hypera SA's daily price indicators and compare them against related drivers.
| Information Ratio | (0.32) | |||
| Maximum Drawdown | 16.16 | |||
| Value At Risk | (3.60) | |||
| Potential Upside | 2.48 |
Additional Tools for Hypera Stock Analysis
When running Hypera SA's price analysis, check to measure Hypera SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hypera SA is operating at the current time. Most of Hypera SA's value examination focuses on studying past and present price action to predict the probability of Hypera SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hypera SA's price. Additionally, you may evaluate how the addition of Hypera SA to your portfolios can decrease your overall portfolio volatility.